期刊文献+

精准医疗体系下临床药师参与肿瘤内科医疗查房的切入点 被引量:3

Exploration and practice of the way of clinical pharmacists participating in medical ward-round of the oncology treatment under precision medicine system
原文传递
导出
摘要 目的探讨精准医疗体系下临床药师参与肿瘤内科医疗查房的切入点。方法在参与肿瘤内科医疗查房中,临床药师结合患者生理、疾病因素,药物特殊作用机制,药动学相互作用,药源性疾病和血药浓度监测结果等因素协助医师促进临床精准用药。结果医师对患者作出正确的诊断后,临床药师协助医师优化治疗方案,保证在正确的时间给予正确的药物和使用正确剂量,达到精准治疗的目的。结论精准医疗体系下,临床药师利用所掌握的专业知识,对患者用药进行综合分析,有利于提高药物治疗效果和减少药物不良反应。
作者 魏娜 翁秀华 曾凡湘 刘茂柏 WEI Na;WENG Xiuhua;ZENG Fanxiang
出处 《中国临床药学杂志》 CAS 2019年第5期382-384,共3页 Chinese Journal of Clinical Pharmacy
  • 相关文献

参考文献5

二级参考文献70

  • 1王波,江森.关于5-氟尿嘧啶应用者血药浓度监测的研究[J].实用肿瘤杂志,1993,8(3):185-187. 被引量:1
  • 2楼雅卿,赵莉.奥美拉唑(Omeprazole)的临床药代动力学研究进展[J].中国临床药理学杂志,1993,9(4):237-245. 被引量:12
  • 3邓艳萍,楼雅卿.己酮可可碱(Pentoxifylline)临床药代动力学进展[J].中国临床药理学杂志,1994,10(4):228-233. 被引量:1
  • 4Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med, 2004, 350(21): 2129-2139.
  • 5Melosky B. Treatment algorithms for patients with metastatic non- small cell, non-squamous lung cancer[J]. Front Oncol, 2014, 4: 256.
  • 6Ye T, Pan -, Wang R, et al. Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old[J]. J Thorac Dis, 2014, 6(10): 1396-1402.
  • 7Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J]. N Engl J Med, 2002, 346(2): 92-98.
  • 8Jiang J, Liang X, Zhou X, et al. Non-platinum doublets were as effective as platinum-based doublets for chemotherapy-naive advanced non-small-cell lung cancer in the era of third-generation agents[J]. J Cancer Res Clin Oncol, 2013, 139(1): 25-38.
  • 9Scagliotti GV, Pafikh P, von Pawel J, et al. Phase 111 study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J]. J Clin Oncol, 2008, 26(21): 3543-3551.
  • 10Cobo M, Isla D, Massuti B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase HI trial in non-small-ceU lung cancer[J]. J Clin Oncol, 2007, 25(19): 2747-2754.

共引文献270

同被引文献31

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部